Viewing Study NCT00430534


Ignite Creation Date: 2025-12-25 @ 2:19 AM
Ignite Modification Date: 2025-12-27 @ 10:47 PM
Study NCT ID: NCT00430534
Status: COMPLETED
Last Update Posted: 2007-02-02
First Post: 2007-02-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Evaluation of Safety, Immune-Response and Efficacy of GSK Biologicals' EBV (Epstein Barr Virus) Vaccine (268664).
Sponsor: Henogen
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module